Advertisement

Topics

Immuno Concepts N.A. Ltd. Company Profile

12:58 EST 11th December 2018 | BioPortfolio

Immuno Concepts was founded in 1979 with a commitment to advance the quality of diagnostic assays for systemic rheumatic diseases. Over twenty years later we still honor that commitment. Our company motto, "Quality People Setting the Quality Standard," further reflects this commitment. We are proud to display that we have a quality system that is certified to ISO 9001 and we are actively pursuing CE mark certification for our products. In 1979 Immuno Concepts pioneered the conversion from rodent tissue to HEp-2 cells for detection of anti-nuclear antibodies (ANAs). Using genetic engineering we developed HEp-2000, an ANA substrate with increased sensitivity for detection of autoantibodies to SS-A/Ro. The advantages of the HEp-2000 substrate over conventional HEp-2 have been documented in several published papers from well-known institutions and are discussed later in this catalog. Immuno Concepts was the first company to offer a non-fluorescent ANA. Our Colorzyme methodology uses a patented stabilized color reagent system that allows slide-based assays to be read using common bright field microscopy. The Colorzyme format is available for ANA, nDNA and EBV assays

Location

9779 D Business Park Drive
Sacramento
California
95827
United States of America

Contact

Phone: 916-363-2649


News Articles [339 Associated News Articles listed on BioPortfolio]

Entegris: Growing demand for single-use tech drives Flex Concepts buy

Entegris says buying Flex Concepts will help secure its supply of disposable bioprocessing bags and fluid transfer technologies.

Immuno-Oncology Conference 2018

26 - 27 September, London, UK. Immuno-Oncology is a fast-paced field with massive potential to deliver successful and durable cancer therapies. SMi's Immuno-Oncology Conference will focus on a few key...

10 Top Immuno-Oncology Companies

One of the most highly anticipated methods to fight cancer is the immuno-oncology (I/O) sector. For investors interested in the field the Investing News Network (INN) has put together a list of top im...

High-end Cutting Capabilities for Filtration Media

Product AnnouncementAdvanced Filtration Concepts, Inc. introduces the capability to cut many types of filtration media in various shapes and sizes.

Food To Fitness...Franchising Is On The Move

The domination of food concepts in franchising is over, bowing to a plethora of fitness concepts appealing to new and expanding segments of the population.

New ASCO/SITC Guidance Addresses Shortcomings of Immuno-Oncology Trial Reporting

The recommendations on Trial Reporting in Immuno-Oncology aim to enchance understanding of efficacy and toxicity outcomes in immuno-oncology trials.

Health Management Concepts, Inc. Identifies and Addresses Security Incident

SEATTLE, Sept. 11, 2018 /PRNewswire/ -- Today, Health Management Concepts, Inc. ("HMC") announced that it is addressing a security incident involving personal information of the Read more...

Manipulating microglia

Alector’s $133M series E will enable the immuno-neurology and immuno-oncology company to take five programs into the clinic.

PubMed Articles [317 Associated PubMed Articles listed on BioPortfolio]

Immuncheckpoint Inhibitors: Current Indications and Possible Future Concepts.

Immuno-oncological therapy concepts have already achieved great success in the treatment of a number of advanced malignancies, thereby rapidly gaining access to clinical practice. Immuncheckpoint inhi...

Challenges in Immuno-Oncology - Possibilities for Optimization.

Immuno-oncology has undoubtedly started a new era in the treatment of malignant diseases. Within a short time immunotherapeutic therapy concepts have become part of the standard therapy for many tumor...

A Practice-Oriented Review of Health Concepts.

Whereas theories on health generally argue in favor of one specific concept, we argue that, given the variety of health practices, we need different concepts of health. We thus approach health concept...

Demonstration of IgG Subclass (IgG1 and IgG3) in Immuno-Related Hemocytopenia.

Immuno-related hemocytopenia (IRH) is defined as idiopathic cytopenia of undetermined significance (ICUS) patients with autoantibodies. In our previous studies, we found that IgG1 levels were increase...

Complex overlapping concepts: An effective auditing methodology for families of similarly structured BioPortal ontologies.

In previous research, we have demonstrated for a number of ontologies that structurally complex concepts (for different definitions of "complex") in an ontology are more likely to exhibit errors than ...

Clinical Trials [1201 Associated Clinical Trials listed on BioPortfolio]

Exposure Chamber Trial With Cat Immunotherapy

The main purpose of this trial is to investigate if any of three different doses of cat hair immunotherapy is safe for treatment of cat allergic patients.

Compatibility and Immunogenicity of a Short Specific Immunotherapy (SIT) in Contrast to Classic Specific Immunotherapy

We wanted to examine the immunogenicity and safety of a shortened specific immunotherapy in contrast to the standard specific immunotherapy. Therefore, we challenged 12 patients for 14 we...

Study of the Cognition of Patients Treated With Immunotherapy

The investigator's longitudinal pilot study aims to evaluate for the first time the impact of immunotherapy on cognition in oncology. Due to the recent nature of immunotherapy, its side e...

Intralymphatic Immunotherapy in Increasing Doses, After Subcutaneous Immunotherapy

The study evaluates the safety and effect of intralymphatic allergen specific immunotherapy in increasing doses. Patients that have already undergone subcutaneous immunotherapy will be tre...

Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma

The purpose of this study is to determine the safety of making and giving Epstein-Barr virus (EBV) immunotherapy products to subjects with nasopharyngeal carcinoma (NPC) associated with EB...

Companies [299 Associated Companies listed on BioPortfolio]

Immuno Concepts N.A. Ltd.

Immuno Concepts was founded in 1979 with a commitment to advance the quality of diagnostic assays for systemic rheumatic diseases. Over twenty years later we still honor that commitment. Our company m...

AV Concepts

AV Concepts is the inspired place where creative and technology meets. For 24 years AV Concepts has not only been a full-service supplier of video, audio, lighting and technical s...

Simulated Environment Concepts, Inc.

Simulated Environment Concepts, Inc. (SE Concepts) (SYMBOL: SMEV) is an industry leading manufacturer and developer of cutting edge medical, health and wellness equipment.

Simulated Environment Concepts

Simulated Environment Concepts, Inc. (SE Concepts) (SYMBOL: SMEV) is an industry leading manufacturer and developer of cutting edge medical, health and wellness equipment.

Bionor Immuno AS

Bionor Immuno is a multidisciplinary drug discovery company located in Skien, Norway. The major focus of the company is to develop effective peptide based immunotherapies, against infectious diseases ...

More Information about "Immuno Concepts N.A. Ltd." on BioPortfolio

We have published hundreds of Immuno Concepts N.A. Ltd. news stories on BioPortfolio along with dozens of Immuno Concepts N.A. Ltd. Clinical Trials and PubMed Articles about Immuno Concepts N.A. Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Immuno Concepts N.A. Ltd. Companies in our database. You can also find out about relevant Immuno Concepts N.A. Ltd. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record